• Onomatopoeia@lemmy.cafe
    link
    fedilink
    English
    arrow-up
    4
    arrow-down
    5
    ·
    20 days ago

    And we’re already starting to see negative consequences.

    How about you fully test a drug before throwing it out in the world and then blaming patients for “not knowing how it works, so you should’ve used it differently”.

    Over the next 20 years we’ll see all the risks come to light before it then gets pulled.

    Wash, rinse, repeat.

      • Warl0k3@lemmy.world
        link
        fedilink
        English
        arrow-up
        4
        ·
        20 days ago

        As far as I’ve seen, use comes with a very slightly increased chance of kidney failure, pancreatitis and a rare form of thyroid cancer. These are known and well studied drugs that are being used to treat different conditions than they previously were, so there’s not some huge lack of information as was implied. Idk what they’re referring to specifically, but that’s everything I’ve been able to find from looking into them recently.

      • Klairabelle@lemmy.world
        link
        fedilink
        English
        arrow-up
        1
        ·
        19 days ago

        Just gonna say this, there is a massive amount of work that goes into creation, validation, and maintenance of information for these drugs even after they’re out on the market. These may have become a hot drug category as soon as it caught on that it was good for treating obesity as well as diabetes, but that doesn’t mean that they aren’t continually doing work in the background to keep information, including incidences and likelihood of side effects, up to date.

    • deafboy@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      19 days ago

      I feel like drugs for treating obesity are perceived differently by the general public, compared to other drugs. There are always folks willing to regulate them out of use entirely. Why?